Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Clinical trial NCT06959706 · RECRUITING
Trial details
- NCT number
- NCT06959706
- Sponsor
- Tagworks Pharmaceuticals BV
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-07
- Primary completion
- 2026-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.